Ciaran P. Brady, Ph.D., Associate Director, Biopharmaceutical Development, Human Genome Sciences
Laurel Donahue-Hjelle, Ph.D., Director, New Product Development, Life Technologies
Chetan T. Goudar, Ph.D., P.E., Head, Cell Culture Development, Global Biological Development, Bayer HealthCare
Denny Kraichely, Ph.D., Associate Director, CMC Team Lead, Portfolio Management & Technical Integration, Johnson & Johnson Pharmaceutical R&D, Inc.
Chris Dowd, Ph.D., Senior Engineer, Late Stage Purification, Genentech, Inc.
Christopher Gallo, Ph.D., Associate Research Fellow, Purification Process Development, Biotherapeutics Pharm. Sci., Pfizer Inc.
Uwe Gottschalk, Ph.D., Vice President, Purification Technology, Sartorius Stedim Biotech, Germany
Günter Jagschies, Ph.D., Senior Director R&D, Strategic Customer Relations, GE Healthcare Life Sciences, Sweden
John Joly, Ph.D., Director of Early Stage Cell Culture, Process Development, Genentech, Inc.
Natraj Ram, Ph.D., Senior Group Leader, Purification, Technical Operations, Abbott Bioresearch Center
Norbert Schuelke, Ph.D., Associate Director, Millennium Pharmaceuticals Inc
Andrew Snowden, Ph.D., Principal Scientist, Amgen, Inc.
Seshu Tyagarajan, Ph.D., Associate Director, CMC-Project Management, ImClone
Tim Tressel, Ph.D., Director, Purification Process Development, Amgen, Inc.
